Shares of Owens & Minor (OMI) plummeted 5.28% in Thursday's trading session following the release of its first-quarter 2025 financial results. The medical supplies company reported mixed results, with revenue falling short of expectations while adjusted earnings per share beat estimates.
Owens & Minor reported Q1 revenue of $2.632 billion, missing analysts' expectations of $2.658 billion. The company also posted a net loss of $25 million for the quarter, contributing to the negative market reaction. Despite these challenges, adjusted earnings per share came in at $0.23, surpassing the estimated $0.20.
The company provided its full-year outlook, projecting adjusted EPS between $1.60 and $1.85, and revenue in the range of $10.85 billion to $11.15 billion. Additionally, Owens & Minor stated that it remains "actively engaged in the potential sale of Products & Healthcare Services Segment," which may be influencing investor sentiment. The market's response suggests concerns about the company's overall financial health and future prospects, despite some positive elements in the earnings report.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。